Lista de obras -

A comparison of alternative assessments of depressive symptom severity: a pilot study

artículo científico publicado en 2000

A comparison of alternative assessments of depressive symptom severity: a pilot study.

artículo científico publicado en 2000

A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report

artículo científico publicado en 2006

Acceptability of second-step treatments to depressed outpatients: a STAR*D report

artículo científico publicado en 2007

An evaluation of the quick inventory of depressive symptomatology and the hamilton rating scale for depression: a sequenced treatment alternatives to relieve depression trial report.

artículo científico publicado en 2005

Brief psychiatric rating scale expanded version: How do new items affect factor structure?

artículo científico publicado en 2005

Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.

artículo científico publicado en 2006

Clinical and sociodemographic characteristics associated with suicidal ideation in depressed outpatients

artículo científico publicado en 2013

Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D.

artículo científico publicado en 2004

Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project.

artículo científico publicado en 2004

Comorbid psychiatric disorders in depressed outpatients: demographic and clinical features.

artículo científico publicado en 2005

Comparison of self-report and clinician ratings on two inventories of depressive symptomatology.

artículo científico publicado en 2006

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

artículo científico publicado en 2006

Family history of mood disorder and characteristics of major depressive disorder: a STAR*D (sequenced treatment alternatives to relieve depression) study.

artículo científico publicado en 2006

Identifying risk for attrition during treatment for depression

artículo científico publicado en 2009

Income and attrition in the treatment of depression: a STAR*D report.

artículo científico publicado en 2009

Medication augmentation after the failure of SSRIs for depression.

artículo científico publicado en 2006

Medication treatment for the severely and persistently mentally ill: the Texas Medication Algorithm Project.

artículo científico publicado en 1999

Methods of testing feasibility for sequenced treatment alternatives to relieve depression (STAR*D).

artículo científico publicado en 2004

One-year clinical outcomes of depressed public sector outpatients: a benchmark for subsequent studies.

artículo científico publicado en 2004

Release bias in accessing medical records in clinical trials: a STAR*D report.

artículo científico publicado en 2009

Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design

artículo científico publicado en 2004

Texas Medication Algorithm Project, phase 3 (TMAP-3): clinical results for patients with a history of mania.

artículo científico publicado en 2003

Texas Medication Algorithm Project, phase 3 (TMAP-3): rationale and study design.

artículo científico publicado en 2003

The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a

artículo científico publicado en 2004

The Texas medication algorithm project: clinical results for schizophrenia.

artículo científico publicado en 2004

Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.

artículo científico publicado en 2006

Voice response system to measure healthcare costs: a STAR*D report.

artículo científico publicado en 2009

Web-based communications and management of a multi-center clinical trial: the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) project

artículo científico publicado en 2004

What clinical and symptom features and comorbid disorders characterize outpatients with anxious major depressive disorder: a replication and extension

artículo científico publicado en 2006

What predicts attrition in second step medication treatments for depression?: a STAR*D Report.

artículo científico publicado en 2008

Lista de obras de

A comparison of alternative assessments of depressive symptom severity: a pilot study

A comparison of alternative assessments of depressive symptom severity: a pilot study.

A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report

Acceptability of second-step treatments to depressed outpatients: a STAR*D report

An evaluation of the quick inventory of depressive symptomatology and the hamilton rating scale for depression: a sequenced treatment alternatives to relieve depression trial report.

Brief psychiatric rating scale expanded version: How do new items affect factor structure?

Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.

Clinical and sociodemographic characteristics associated with suicidal ideation in depressed outpatients

Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D.

Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project.

Comorbid psychiatric disorders in depressed outpatients: demographic and clinical features.

Comparison of self-report and clinician ratings on two inventories of depressive symptomatology.

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

Family history of mood disorder and characteristics of major depressive disorder: a STAR*D (sequenced treatment alternatives to relieve depression) study.

Identifying risk for attrition during treatment for depression

Income and attrition in the treatment of depression: a STAR*D report.

Medication augmentation after the failure of SSRIs for depression.

Medication treatment for the severely and persistently mentally ill: the Texas Medication Algorithm Project.

Methods of testing feasibility for sequenced treatment alternatives to relieve depression (STAR*D).

One-year clinical outcomes of depressed public sector outpatients: a benchmark for subsequent studies.

Release bias in accessing medical records in clinical trials: a STAR*D report.

Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design

Texas Medication Algorithm Project, phase 3 (TMAP-3): clinical results for patients with a history of mania.

Texas Medication Algorithm Project, phase 3 (TMAP-3): rationale and study design.

The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a

The Texas medication algorithm project: clinical results for schizophrenia.

Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.

Voice response system to measure healthcare costs: a STAR*D report.

Web-based communications and management of a multi-center clinical trial: the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) project

What clinical and symptom features and comorbid disorders characterize outpatients with anxious major depressive disorder: a replication and extension

What predicts attrition in second step medication treatments for depression?: a STAR*D Report.